Start here: a real deficit, an imported explanation
Two things are true at once. First, when researchers measure blood volume in people with POTS, many come up low, often well below what their body size predicts. That is a solid, reproducible finding. Second, the leap from that general POTS finding to a confident claim about your long COVID is partly an import, not a long-COVID-specific proof.
Holding both keeps you honest. The mechanism is biologically sound and worth acting on, and the precise size of its role in post-COVID POTS is still being worked out. This page treats it as a strong candidate driver, not a settled verdict.
blood-volume deficit is measurable in POTSthin specifically in long COVIDimported from general POTS literature
Why low volume makes the heart race
Standing pulls roughly half a litre of blood downward into the legs and abdomen. Normally the vessels tighten and the volume is enough to keep blood returning to the heart. If the starting volume is low, there is less to return, the heart fills less with each beat, and the only way to keep output up is to beat faster.
That fast beat on standing is the defining sign of POTS. Framed this way, the tachycardia is not the disease itself but a compensation for a delivery problem. It is why volume-expanding steps can ease symptoms even though they do not cure the underlying condition.
What the measurements show
Foundational autonomic research established that blood volume is low in a large share of POTS patients, and that the deficit spans red cells and plasma rather than simple dehydration. More recent work using a rebreathing method to measure volume directly found total blood volume in POTS running well below predicted, with the size of the deficit tracking how high the heart rate climbed on standing.
That correlation, bigger deficit, faster standing heart rate, is the kind of dose-response link that strengthens a causal reading. It does not prove the deficit started the illness, but it ties the number directly to the symptom people feel.
deficit correlates with upright heart ratemeasured directly, not inferred
Cause, consequence, or both
The honest gap is direction. Low volume could be a primary problem in the kidneys and hormones that set fluid balance, or it could be partly downstream of being unwell, less upright time, altered salt and water handling, and reduced activity. In long COVID both routes are plausible and probably mix.
This matters because it shapes expectations. If volume is largely a consequence, expanding it eases symptoms but other drivers remain. If it is closer to a root cause in a given person, volume strategies may do more. The research has not cleanly separated these in post-COVID POTS.
What follows for management
The practical upshot is gentle and low-risk. Increasing fluid and salt, using compression garments over the legs and abdomen, and avoiding long motionless standing all aim to put more effective volume back into circulation. None of these is a cure, and they help many people meaningfully.
Because the volume story is borrowed rather than proven for long COVID, treat these as a supported trial rather than a guarantee. They are safe enough to try and to keep if they help, and their failure in one person does not mean the mechanism is absent, only that it is not the dominant driver for them.
How to read strong claims about it
If a source states flatly that low blood volume causes your long COVID POTS, it is overreaching past the evidence. If a source dismisses volume entirely, it is ignoring reproducible measurements. The accurate position sits between: a measurable, treatable contributor whose exact weight varies by person.
That middle reading is also the most useful. It justifies trying the simple volume strategies, sets realistic expectations, and keeps the door open to the other mechanisms, autonomic, low serotonin, and clotting, that share the stage in post-COVID orthostatic intolerance.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- Whether low blood volume is a primary cause or a downstream consequence in post-COVID POTS.
- What share of long COVID POTS patients actually have a measurable volume deficit.
- Why fluid-regulating hormones behave abnormally in some POTS patients.
- Whether early volume expansion changes the long-term course or only daily symptoms.
- How volume interacts with the serotonin and autoantibody mechanisms also proposed for POTS.
- The best practical way to measure volume status in ordinary clinics.
What this means for you
Low blood volume is one of the better-supported pieces of the POTS picture, and the simple steps that target it, more fluid and salt, compression, avoiding still standing, are safe to try and help many people. Treat benefit as a welcome signal, not a diagnosis confirmed.
Be wary of sources that make it the whole story or dismiss it entirely. For long COVID specifically the role is borrowed from general POTS research and still being sized. That is a reason to try the low-risk measures and to keep looking at the other drivers, not a reason to wait.
References
Each reference links to the source on PubMed, PMC, or the publisher.